20-Feb-2026
Pediatrix Medical Earnings Call Highlights Steady Margin Focus
TipRanks (Thu, 19-Feb 7:28 PM ET)
Seeking Alpha News (Thu, 19-Feb 5:25 PM ET)
Market Chameleon (Thu, 19-Feb 4:17 AM ET)
TipRanks (Thu, 19-Feb 8:15 AM ET)
Pediatrix Medical Group Non-GAAP EPS of $0.50 misses by $0.04, revenue of $494M beats by $7.77M
Seeking Alpha News (Thu, 19-Feb 6:09 AM ET)
Pediatrix Medical Group Reports Fourth Quarter Results
Business Wire (Thu, 19-Feb 6:00 AM ET)
Here are the major earnings before the open Thursday
Seeking Alpha News (Wed, 18-Feb 6:00 PM ET)
Pediatrix Medical Group Q4 2025 Earnings Preview
Seeking Alpha News (Wed, 18-Feb 1:02 PM ET)
Business Wire (Mon, 9-Feb 6:45 AM ET)
Market Chameleon (Mon, 3-Nov 6:52 AM ET)
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Pediatrix Medical Group trades on the NYSE stock market under the symbol MD.
As of February 20, 2026, MD stock price declined to $18.82 with 1,812,165 million shares trading.
MD has a beta of 0.66, meaning it tends to be less sensitive to market movements. MD has a correlation of 0.05 to the broad based SPY ETF.
MD has a market cap of $1.64 billion. This is considered a Small Cap stock.
Last quarter Pediatrix Medical Group reported $494 million in Revenue and $.50 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.02.
In the last 3 years, MD traded as high as $24.99 and as low as $6.62.
The top ETF exchange traded funds that MD belongs to (by Net Assets): IJR, VTI, VB, IWM, VBR.
MD has underperformed the market in the last year with a price return of +9.2% while the SPY ETF gained +14.1%. MD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -17.2% and -9.9%, respectively, while the SPY returned +6.0% and -0.2%, respectively.
MD support price is $18.81 and resistance is $19.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MD shares will trade within this expected range on the day.